MEDIKAMENTENABGABEVORRICHTUNG

Patent europeic · EP3380139 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3380139
Numer da la dumonda
EP16798203
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
21-11-2016
Publitgà
03-10-2018
Concedì
04-03-2020
La protecziun finescha il pli tard
20-11-2036
Proxima taxa annuala scadenta
30-11-2026
Classas IPC
A61M 5/20 (2006.01)
A61M 5/24 (2006.01)
A61M 5/28 (2006.01)
A61M 5/32 (2006.01)
Prioritad
EP 15196699 27.11.2015
Dumonda PCT
PCT/EP2016/078267 21.11.2016
Publicaziun PCT
WO2017/089278 01.06.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-12-2025

    Midada

    Published in Swissreg on 01.12.2025

  2. 01-12-2024

    Midada

    Published in Swissreg on 01.12.2024

  3. 01-12-2023

    Midada

    Published in Swissreg on 01.12.2023

  4. 01-12-2022

    Midada

    Published in Swissreg on 01.12.2022

  5. 04-03-2020

    Concedì

    Published in Swissreg on 04.03.2020

Partidas

Possessur

Sanofi-Aventis Deutschland GmbH

Brüningstraße 50, 65929 Frankfurt am Main, DE

Inventur

HUTHMACHER, Winfried

60389 Frankfurt, DE

SCHADER, Marc

65926 Frankfurt am Main, DE

HELMER, Michael

65926 Frankfurt am Main, DE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.